Connor, Clark & Lunn Investment Management (CC&L)
CLB icon

Connor, Clark & Lunn Investment Management (CC&L)’s Core Laboratories CLB Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$496K Buy
+29,541
New +$529K ﹤0.01% 1314
2019
Q2 		– Sell
-16,975
Closed -$1.17M – 999
2019
Q1 		$1.17M Buy
16,975
+6,575
+63% +$441K 0.01% 500
2018
Q4 		$620K Buy
+10,400
New +$897K ﹤0.01% 653
2017
Q4 		– Sell
-4,450
Closed -$439K – 790
2017
Q3 		$439K Buy
+4,450
New +$431K ﹤0.01% 655
2014
Q1 		– Sell
-1,307
Closed -$265K – 688
2013
Q4 		$265K Buy
+1,307
New +$243K ﹤0.01% 623

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CLB Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Core Laboratories (CLB) in Q1 2026: 29,541 shares worth $496K. The stake represents ﹤0.01% of the portfolio and ranks #1314 among its holdings. This is a return to the name: Connor, Clark & Lunn Investment Management (CC&L) previously reported a position in CLB as recently as Q1 2019.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CLB in Q4 2013 and has held it in 5 quarters since. The position peaked at $1.17M in Q1 2019. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 29,541 shares of Core Laboratories worth $496K as of Q1 2026.
  • Core Laboratories was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q1 2026.
  • Core Laboratories made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #1314 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Core Laboratories in Q4 2013 and has held it in 5 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Core Laboratories position peaked at $1.17M in Q1 2019.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.